HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients

BACKGROUND: HIV-1 integrase (IN) variability in treatment naïve patients with different HIV-1 subtypes is a major issue. In fact, the effect of previous exposure to antiretrovirals other than IN inhibitors (INI) on IN variability has not been satisfactorily defined. In addition, the genetic barrier...

Descripción completa

Detalles Bibliográficos
Autores principales: Piralla, Antonio, Paolucci, Stefania, Gulminetti, Roberto, Comolli, Giuditta, Baldanti, Fausto
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077329/
https://www.ncbi.nlm.nih.gov/pubmed/21453487
http://dx.doi.org/10.1186/1743-422X-8-149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077329/
https://www.ncbi.nlm.nih.gov/pubmed/21453487
http://dx.doi.org/10.1186/1743-422X-8-149

Ejemplares similares